Several studies have reported alterations in mitochondrial morphology, reductions in mitochondrial mass, impaired oxidative capacity, and altered expression of peroxisome proliferator--activated receptor-γ coactivator-1α (PGC-1α) ([@B1],[@B2]) in the skeletal muscle of insulin-resistant individuals. This impairment in mitochondrial function results in a decrease in glucose and fatty acid oxidation and an increase in intramuscular triglycerides and insulin resistance ([@B3]). Emerging evidence suggests that adaptations to heavy lipid load depend on the coordinated actions of transcriptional regulators such as the peroxisome proliferator--activated receptors (PPARs) and PGC-1α ([@B4]). Chronic exercise ([@B5]) enhances muscular mitochondrial biogenesis and performance, favoring tighter coupling between β-oxidation and trichloroacetic acid cycle, and may concomitantly improve insulin sensitivity. PGC-1α was suggested to play a key role in coordinating metabolic flux and mitochondrial biogenesis ([@B6],[@B7]).

Besides an increase in size and number of mitochondria, chronic exercise results in the induction of mitochondrial transporters, enzymes involved in β-oxidation of fatty acids, or enzymes of the mitochondrial respiratory chain in the muscle. Mitochondrial biogenesis requires the coordination of the nuclear and mitochondrial genome. Transcription factors involved in this process include PGC-1α, the nuclear respiratory factors (NRF-1/NRF-2), and the mitochondrial transcription factor A (Tfam), which are downstream of PGC-1α ([@B6]). PGC-1α is preferentially expressed in muscles enriched in slow-twitch type I fibers and drives the formation of slow-twitch fibers ([@B8]). Exercise was shown to result in an increased PGC-1α expression ([@B9]). The induction of PGC-1α expression and the concomitant increase in mitochondrial biogenesis in muscle involves the activation of calcium/calmodulin-dependent protein kinase (CaMK), p38 mitogen-activated protein kinase ([@B9],[@B10]), or AMP-dependent protein kinase (AMPK) ([@B11]). AMPK phosphorylates PGC-1α at Thr177 and Ser538, which is required for the PGC-1α--dependent induction of the PGC-1α promoter and the mitochondrial biogenic response ([@B12]). However, the extent of endurance training may determine whether the CaMK or the AMPK pathway is primarily activated ([@B13]).

PGC-1α activity is influenced by various posttranslational modifications. AMP-activated protein kinase ([@B12]), p38 MAPK ([@B9],[@B10]), and protein kinase B (Akt) ([@B14]) phosphorylate PGC-1α, modifying its stability and activity (rev. in [@B15]). Besides these phosphorylation sites, PGC-1α contains multiple distinct acetylation sites. PGC-1α deacetylation has been demonstrated to occur via SIRT1 in vitro as well as in vivo during fasting ([@B7],[@B16]) and can be mimicked by resveratrol ([@B17]). Furthermore, an exercise-induced increase in SIRT1 activity has been described in both heart and adipose tissue ([@B18]). Recently, a reduced PGC-1α acetylation was described after a single session of exercise ([@B19]). In addition, the mechanisms underlying the interaction between PGC-1α deacetylation by SIRT1 and PGC-1α phosphorylation by AMPK have been investigated in detail ([@B19]).

However, the effects of chronic exercise on AMPK-induced and SIRT1-mediated deacetylation of PGC-1α have not been investigated so far. Exercise is associated with an intermittent increase in muscular AMP content during the replenishing of cellular ATP and can thus result in the activation of AMPK by a repetitive increase in intracellular AMP-to-ATP ratio ([@B20]). The posttranslational modifications of PGC-1α induced by fasting ([@B7],[@B16],[@B21]), high-fat diet ([@B21]), or physical activity ([@B19]) may contribute to changes in mitochondrial function, energy metabolism, and insulin sensitivity. Because of the major role of PGC-1α in the control of both energy metabolism and insulin sensitivity, it is seen as a candidate factor in the etiology of type 2 diabetes and a drug target for its therapy.

Leptin ([@B22]) and adiponectin ([@B23],[@B24]) have both been shown to activate AMPK and may thus promote mitochondrial biogenesis. Adiponectin directly improves mitochondrial function, increases the number of mitochondria, and exerts antidiabetic effects ([@B24]). Leptin deficiency on the other hand is associated with impaired mitochondria ([@B25]). Furthermore, *ob/ob* mice with premature obesity show lower levels of circulating adiponectin ([@B26]) and reduced muscle AMPK phosphorylation ([@B27]) compared with wild-type mice.

Therefore, the purpose of the present study was to investigate the influence of impaired adipokine-related AMPK activation on exercise-mediated effects on mitochondrial function and biogenesis in the skeletal muscle of *ob/ob* mice with early-onset obesity in comparison to wild-type mice. In addition, we tried to define the influence of physical activity on PGC-1α acetylation as a putatively important determinant of mitochondrial biogenesis.

RESEARCH DESIGN AND METHODS
===========================

Animals and exercise protocol.
------------------------------

Mice heterozygous for the obese spontaneous mutation (*Lep^ob^* commonly referred to as *ob*) on a C57BL/6J background were purchased from Jackson Laboratories. Animals were housed in an environmentally controlled laboratory with a 12-h/12-h light--dark cycle with two to four mice in each cage. Age-matched male *ob/ob* mice and the corresponding littermates (wild-type mice on a C57BL/6J background) were randomly assigned to the sedentary control group (C, *n* = 6 per group) or the training group (T, *n* = 6 per group). Treadmill exercise training on an Exer 3/6 treadmill (equipped with a stimulus assembly; Columbus Instruments) started at age 10--12 weeks. We tested critical speed in both mouse strains at the age of 10--12 weeks in a pilot experiment. Critical speed during involuntary treadmill exercise performance in C57BL/6J mice, as used here in the present study, has been shown to be low compared with other commonly used mouse strains ([@B28],[@B29]). Although voluntary exercise avoids some of the stressful factors related to forced training, we used treadmill exercise, since *ob/ob* mice are very resistant to spontaneous running. Running speed was lowest in the *ob/ob* mice and was therefore adjusted in both mouse strains according to the critical speed determined for the *ob/ob* mice. The highest speed tolerated by the *ob/ob* mice was 15 m/min. This maximum speed was therefore used in the wild-type mice as well. Pilot experiments also showed that exhaustion in both mouse strains occurred after ∼60--70 min at this speed. Two weeks before the experimental period, the treadmill speed was gradually increased from 5 to 15 m/min and 10% incline. During the following 12 weeks, a 10-min warming up at 10 m/min was followed by 60 min exercise at a speed of 15 m/min and a 10-min cool down at a speed of 10 m/min (5 days weekly). Concurrently, matched untrained mice maintained familiarity with the treadmill (5 m/min, 0 degrees incline, 15-min duration, three times/week).

For measurement of fasting serum parameters 24 h after the last exercise, food was withdrawn for 12 h before death by cervical dislocation. Muscles were removed 24 h after the last exercise session, dissected, and stored in liquid nitrogen if not otherwise stated. Blood was drawn by aortic puncture at that time.

To investigate whether the changes observed after chronic exercise can be mimicked by a single bout of exercise, we performed additional experiments in a subset of C57BL/6J and *ob/ob* mice. Animals were acclimatized to the treadmill before the running test. For the habituation, mice were run at 10 m/min for 15 min on the day before the test. For the actual test, the speed was gradually increased from 5 to 15 m/min and a 10% incline. Mice were run until exhaustion, which was assumed when mice received more than five shocks in a 2-min interval. Average running distance was 1,050 ± 69 m in C57BL/6J mice and 989 ± 93m in *ob/ob* mice. Mice were either killed 6 or 24 h after the exercise test (*n* = 6 per group). Nonexercising C57BL/6J and *ob/ob* mice served as the respective control groups (*n* = 6 per group). The protocols were approved by the Animal Care and Use Committee of the Martin Luther University Halle-Wittenberg.

Tissue sampling.
----------------

Mouse gastrocnemius muscle is a heterogeneous tissue ([@B30]). To avoid this problem, we carefully dissected the gastrocnemius muscle before analyses by respirometric measurements or before freezing in small aliquots in liquid nitrogen (for gene expression analyses as well as enzymatic measurements) and used only the deep red portion. Although fiber composition of the deep red portion of gastrocnemius muscle was not evaluated in the present study, it can be distinguished macroscopically from the white portion. There are data on gastrocnemius fiber composition from rats available in the literature ([@B31]), showing a clear difference between the deep-red and the superficial-white portion of the muscle.

RNA and DNA extraction.
-----------------------

Total RNA was isolated from frozen tissue (deep-red portion of the gastrocnemius muscle) by guanidine thiocyanate/cesium chloride centrifugation. Integrity and quality of the RNA was confirmed by agarose gel electrophoresis, and the concentration was determined by measuring ultraviolet absorption. DNA isolation was performed with the Puregene DNA isolation kit (Biozym).

Real-time PCR.
--------------

Reverse transcription of RNA samples (500 ng total RNA) was carried out for 30 min at 42°C using the SuperScript III First-Strand cDNA Synthesis Kit (Invitrogen). Real-time PCR (primer sequences, [Table 1](#T1){ref-type="table"}) and data analysis were performed using the Mx3000P Multiplex Quantitative PCR System (Stratagene) as described previously ([@B32]). 18S rRNA expression was not affected by any of the interventions and was therefore used as a housekeeping gene. All data of mRNA are given as relative units of 18S rRNA concentrations (18S rRNA control kit, Yakima Yellow-Eclipse Dark Quencher; Eurogentec). The relative copy number of mtDNA per diploid nuclear genome was measured as described previously ([@B33]) using a fragment of mtDNA and a fragment of β-globin.

###### 

Primer sequences

                 GenBank accession number       Forward primer              Reverse primer
  -------------- ------------------------------ --------------------------- -------------------------
  COX III        [AY999076](AY999076)           CGTGAAGGAACCTACCAAGG        ATTCCTGTTGGAGGTCAGCA
  Cytochrome b   [AY999076](AY999076)           CCCTAGCAATCGTTCACCTC        TCTGGGTCTCCTAGTATGTCTGG
  β-Globin       [NM_008220](NM_008220)         TGGGTAATCCCAAGGTGAAG        TTCTCAGGATCCACATGCAG
  Mitofusin-2    [NM_133201](NM_133201)         GGGGCCTACATCCAAGAGA         AAAAAGCCACCTTCATGTGC
  ND5            [AY999076](AY999076)           ACCAGCATTCCAGTCCTCAC        ATGGGTGTAATGCGGTGAAT
  NRF-1          [BC005410](BC005410)           GCACCTTTGGAGAATGTGGT        GGGTCATTTTGTCCACAGAGA
  NRF-2          [U20532](U20532)               CCAGCTACTCCCAGGTTGC         CCTGATGAGGGGCAGTGA
  PGC-1α         [NM_00894](NM_00894)           AAACTTGCTAGCGGTCCTCA        TGGCTGGTGCCAGTAAGAG
  PEPCK          [NM_011044](NM_011044)         AGTGCCCATCCCCAAAACT         CACCACATAGGGCGAGTCTG
  SIRT1          [NM_019812](NM_019812)         AAAGGAATTGGTTCATTTATCAGAG   TTGTGGTTTTTCTTCCACACA
  Tfam           [NM_009360](NM_009360)         CCTTCGATTTTCCACAGAACA       GCTCACAGCTTCTTTGTATGCTT
  CDS            [NM_173370](NM_173370)         TGTTCCCATATCAAGCGTCA        GGCTCACACTCTGTCACGAA
  PGPS           [NM_133757](NM_133757)         CGACCTCAAGGTCTCCATTC        GTTTGCACCACTCAGGATGA
  CLS            [NM_025646](NM_025646)         ATCAGCTTTGGGAAGTGCTC        ACCTTGCTGATGAATGTTGGT
  MLCL AT        [NM_001081071](NM_001081071)   CCCAAGAACCACTGGCTTTA        TTTCTTCCCACCTTCTGTGG
  Tafazzin       [NM_181516](NM_181516)         CTGGGGGATCCTAAAACTCC        AGCGCAGGAACTCAGAACTC

Western blotting and immunoprecipitation.
-----------------------------------------

Protein samples from frozen tissue (deep-red portion of the gastrocnemius muscle) were prepared as described previously ([@B32]). A total of 50 μg protein was separated by SDS-PAGE gel and immunoblotted with antibodies directed against SIRT1 (1:2,000; Upstate), PGC-1α (1:1,000; Santa Cruz), phospho-AMPK (Thr172, 1:1,000) and phospho-acetyl CoA carboxylase (Ser79, 1:1,000; both Cell Signaling Technology), and GAPDH (1:3,000; Abcam). After incubation with peroxidase-conjugated secondary antibody (1:10,000), blots were subjected to the enhanced chemiluminescent detection method (Amersham) and exposed to a film. PGC-1α protein expression was calculated from both bands observed on Western blots.

To obtain protein extracts from tissue samples for immunoprecipitation, 50 mg frozen tissue was rapidly homogenized in 250 μl cold lysis buffer (25 mmol/l Tris HCl, pH 7.9, 5 mmol/l MgCl~2~, 10% glycerol, 100 mmol/l KCl, 1% NP40, 0.3 mmol/l dithiothreitol, protease/phosphatase inhibitor cocktail, 10 mmol/l nicotinamide, and 1 μmol/l Trichostatin A (TSA) with a Precellys 24 Homogenizer (Peqlab), sonicated, and separated by centrifugation. A total of 1,000 μg protein from muscle samples were used for immunoprecipitation. Extracts were diluted with two volumes PBS and incubated with anti--PGC-1α antibody (1 μg antibody/250 μg total protein; Santa Cruz) rotating at 4°C overnight. Immunoprecipitates were then further incubated with protein A/G agarose (Santa Cruz) at 4°C. The beads were collected by centrifugation and washed with PBS. After the final wash, the samples were dissolved in 2 × SDS sample buffer and boiled. The immunoprecipitates were then separated by SDS-PAGE and immunoblotted using an acetyl-lysine antibody (1:1,000; Cell Signaling Technology) and anti--PGC-1α antibody, respectively.

Preparation of skinned fibers and respirometric measurements.
-------------------------------------------------------------

Immediately before oxygraphic measurements, the muscular fibers (deep-red portion of the gastrocnemius muscle) were permeabilized 30 min with saponin. After removal of saponin and adenine nucleotides, the measurements were performed on an OROBOROS oxygraph at 30°C in incubation medium (75 mmol/l mannitol, 25 mmol/l sucrose, 100 mmol/l KCl, 10 mmol/l KH~2~PO~4~, 0.5 mmol/l EDTA, 5 mmol/l MgCl~2~, 20 mmol/l Tris-HCl, and 1 mg/ml BSA) using different substrates: 10 mmol/l pyruvate + 2 mmol/l malate and 10 mmol/l succinate + 5 μmol/l rotenone. The weight-specific oxygen consumption was calculated as the time derivative of the oxygen concentration (DATGRAPH Analysis software, OROBOROS).

Determination of enzyme activities.
-----------------------------------

Small pieces of frozen tissue (deep-red portion of the gastrocnemius muscle) were homogenized in a solution containing 50 mmol/l Tris buffer (pH 7.5), 100 mmol/l potassium chloride, 5 mmol/l MgCl~2~, and 1 mmol/l EDTA using a glass/glass homogenizer. Enzyme activities were referenced to the activity of the mitochondrial marker enzyme citrate synthase. The activity of complex I, complex I + III, complex II + III, complex III, complex II, and complex IV were performed as described previously ([@B34]) using a Cary 50 spectrophotometer (Varian GmbH, Darmstadt, Germany).

Serum analyses.
---------------

Serum adiponectin, leptin, tumor necrosis factor (TNF)-α, and insulin were measured by using commercial enzyme-linked immunosorbent assays (Mouse/Rat Adiponectin ELISA kit, B-Bridge International; Mouse/Rat Leptin ELISA kit, BioVendor; Mouse TNF-α ELISA kit, Raybiotech; Mouse Insulin ELISA, Mercodia). Serum values for glucose were determined with a Glucose Assay Kit (BioCat). Triglycerides were measured using a commercial kit (GPO Trinder; Sigma). Blood lactate concentration was determined three times in all mice: at the beginning of the chronic exercise, after 6 weeks of exercise, and at the end of the last session. Blood was collected from the tip of the tail for this purpose immediately after the end of the session, and lactate was measured with an enzymatic Lactate Assay Kit (BioCat).

Cell culture.
-------------

C2C12 myoblasts were cultured in Dulbecco\'s modified Eagle medium supplemented with 10% FBS, 2 mmol/l [l]{.smallcaps}-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (all PAA) in 5% CO~2~ at 37°C in a humidified chamber. Cells were treated with 25, 50, 100, or 200 ng/ml of mouse recombinant leptin (BioVendor) or 500 ng/ml of mouse recombinant adiponectin (BioVendor) for 24 h.

Plasmid construction and transfection.
--------------------------------------

The cDNA of PGC-1α (GenBank accession number [NM_013261](NM_013261)) was amplified by PfuUltra II Fusion HS DNA Polymerase (Stratagene). PCR products were subcloned into pcDNA3.1 (Invitrogen). Site-directed mutations at Thr177 and Ser538 in PGC-1α were introduced by a PCR-based strategy with the QuikChange site-directed mutagenesis kit (Stratagene). Plasmid DNA preparation was performed with the Midi Plasmid Kit (Qiagen). One day before transfection, C2C12 myoblasts were seeded at a density of 5 × 10^5^ cells per well on a six-well dish. DNA transfection was carried out by liposome-mediated transfection using 2 μg plasmid (pcDNA3.1, pcDNA3.1 PGC-1α, pcDNA3.1 PGC1α ΔThr177/ΔSer538) and Lipofectamine 2000 (Invitrogen) as the transfection reagent according to the manufacturer\'s instructions. The next day, cell culture medium was changed, and cells were left untreated or stimulated with adiponectin (BioVendor) for 24 h. C2C12 myoblasts transfected with the empty plasmid (pcDNA3.1) were treated accordingly and served as an internal control for the effects of adiponectin on AMPK activation and PGC-1α deacetylation. Cells were harvested 48 h after transfection.

Statistical analysis.
---------------------

All values are expressed as mean ± SEM. Statistical analysis of differences observed between numeric parameters of all groups was performed by one-way ANOVA using an all pair-wise multiple comparison procedure (Tukey test). Statistical significance was accepted at the level of *P* \< 0.05.

RESULTS
=======

Systemic effects of chronic exercise.
-------------------------------------

Throughout the study, the body weight was higher in *ob/ob* mice than in C57BL/6J wild-type mice ([Fig. 1](#F1){ref-type="fig"}). The chronic exercise did not result in less weight gain in any of the trained groups ([Fig. 1](#F1){ref-type="fig"}). Furthermore, chronic exercise did not result in significant changes in epididymal fat pads (C57BL/6: 320 mg ± 26; *ob/ob*: 1,120 mg ± 189, *P* \< 0.001).

![Body weight before and after 3 months of chronic exercise. Black columns: C57BL/6J wild-type mice (12 controls \[C\], 12 trained animals \[T\]); gray columns: *ob*/*ob* mice (6 controls, 6 trained animals). Results obtained from the trained mice are depicted with hatched columns. All data are mean ± SEM. \*\*\**P* \< 0.001.](zdb0011164210001){#F1}

After the first exercise session, blood lactate in both strains showed an increase compared with the respective control mice (C57BL/6J: 3.69 ± 0.48 vs. 5.15 ± 0.43, *P* \< 0.05; *ob/ob*: 3.86 ± 0.64 vs. 6.16 ± 0.52, *P* \< 0.01). After 6 weeks of chronic exercise, blood lactate concentration in the trained C57BL/6J mice was no longer different from the respective control mice (not shown). Blood lactate in trained *ob/ob* mice had decreased but remained higher than in the untrained *ob/ob* mice (3.84 ± 0.35 vs. 5.06 ± 0.73, *P* \< 0.05). After 12 weeks of chronic exercise, blood lactate levels were comparable between the groups ([Table 2](#T2){ref-type="table"}) and did not reveal a statistically significant difference compared with the respective untrained mice.

###### 

Serum/blood parameters at the end of the study

                          C57BL/6J          *ob*/*ob*                                                                                      
  ----------------------- ----------------- ----------------------------------------------- ---------------------------------------------- -----------------------------------------------
  Glucose (mmol/l)        6.72 ± 0.54       4.52 ± 0.62[\*](#TF2-1){ref-type="table-fn"}    15.26 ± 0.98[‡](#TF2-3){ref-type="table-fn"}   12.23 ± 0.95[\*](#TF2-1){ref-type="table-fn"}
  Insulin (ng/ml)         1.55 ± 0.39       0.51 ± 0.15[\*](#TF2-1){ref-type="table-fn"}    10.24 ± 0.65[‡](#TF2-3){ref-type="table-fn"}   10.26 ± 0.42
  Leptin (pg/ml)          1,427.6 ± 242.1   328.8 ± 52.5[\*](#TF2-1){ref-type="table-fn"}   43.6 ± 9.6[§](#TF2-4){ref-type="table-fn"}     36.3 ± 8.9
  Adiponectin (μg/ml)     17.8 ± 0.8        34.4 ± 1.7[\*](#TF2-1){ref-type="table-fn"}     8.1 ± 0.5[†](#TF2-2){ref-type="table-fn"}      8.7 ± 1.3
  Triglycerides (mg/dl)   79.7 ± 14.4       61.2 ± 9.5                                      177.5 ± 18.7[†](#TF2-2){ref-type="table-fn"}   156.9 ± 24.4
  Lactate (mmol)          3.79 ± 0.41       4.52 ± 0.30                                     3.81 ± 0.78                                    4.92 ± 0.22
  TNF-α (pg/ml)           23.6 ± 1.4        24.9 ± 0.9                                      86.2 ± 2.5[‡](#TF2-3){ref-type="table-fn"}     79.2 ± 2.1

\**P* \< 0.05 vs. respective control;

†*P* \< 0.05,

‡*P* \< 0.01,

§*P* \< 0.001 vs. C57BL/6J controls.

Glucose, insulin, and leptin serum levels demonstrated a significant reduction together with a strong induction of serum adiponectin in wild-type mice in response to chronic exercise ([Table 2](#T2){ref-type="table"}), indicating a change in insulin sensitivity in these animals. None of the serum parameters except for minor changes in serum glucose was altered in trained compared with untrained *ob/ob* mice ([Table 2](#T2){ref-type="table"}), pointing to the major impact of the deficient leptin on whole-body metabolism. Furthermore, *ob/ob* mice had higher serum TNF levels than wild-type mice, and these were not altered after chronic exercise ([Table 2](#T2){ref-type="table"}).

Influence of chronic exercise on skeletal muscle mitochondrial biogenesis.
--------------------------------------------------------------------------

The mRNA expression of *ND5* (complex I), cytochrome b (*CYTB*, complex III), *COX III* (complex IV), and the PGC-1α--dependent gluconeogenic gene *PEPCK* (phosphoenolpyruvate carboxykinase) was higher in wild-type mice but not in *ob/ob* mice after 3 months of chronic exercise ([Fig. 2](#F2){ref-type="fig"}*A* and *B*). Furthermore, exercise increased citrate synthase activity in wild-type mice ([Fig. 2](#F2){ref-type="fig"}*C*), suggesting a higher mitochondrial density. This was not observed in *ob/ob* mice in response to chronic exercise ([Fig. 2](#F2){ref-type="fig"}*C*). Accordingly, no significant change in mtDNA content was observed in the *ob/ob* mice ([Fig. 2](#F2){ref-type="fig"}*C*), whereas an ∼40% increase occurred in the wild-type mice ([Fig. 2](#F2){ref-type="fig"}*C*). Similarly, we observed a mild induction of *NRF-1* ([Fig. 3](#F3){ref-type="fig"}*A*) and *Tfam* mRNA ([Fig. 3](#F3){ref-type="fig"}*D*) in wild-type mice but not in *ob/ob* mice. *NRF-2* mRNA ([Fig. 3](#F3){ref-type="fig"}*B*) was not altered in any of the two groups. Mitofusin-2 (*MFN2*) mRNA, which may be involved in PGC-1α--independent mechanisms during mitochondrial turnover and assembly (mitochondrial fusion and fission), was not different among the groups or in response to chronic exercise ([Fig. 3](#F3){ref-type="fig"}*C*). The expression of *PGC-1*α mRNA was doubled only in wild-type mice, whereas PGC-1α protein was not significantly altered in any of the groups ([Fig. 4](#F4){ref-type="fig"}*A* and *B*). Acetylation status of PGC-1α was analyzed, since it has a major impact on PGC-1α activity/stability and was shown to be altered in response to low nutrient conditions ([@B7],[@B16]). As shown in [Fig. 4](#F4){ref-type="fig"}*C* and *D*, PGC-1α acetylation was significantly reduced in trained wild-type mice, whereas *ob/ob* mice showed no difference between the two treatment groups ([Fig. 4](#F4){ref-type="fig"}*C* and *D*). Accordingly, the deacetylase SIRT1, which specifically deacetylates PGC-1α in vivo and in vitro, was induced in these mice but not in *ob/ob* mice ([Fig. 5](#F5){ref-type="fig"}) after chronic exercise.

![Markers of mitochondrial biogenesis after chronic exercise. *A*: Real-time PCR analyses of primary mitochondrial transcripts *ND5* (complex I) and *CYTB* (complex III). *B*: Real-time PCR analyses of primary mitochondrial transcript cytochrome oxidase III (*COX III*; complex IV) and the gluconeogenic phosphoenolpyruvate carboxykinase (*PEPCK*) in skeletal muscle samples. All data are normalized per 18S rRNA. *C*: Citrate synthase enzyme activity (IU/g wet weight) and relative copy number of mtDNA per diploid nuclear genome in the deep-red portion of the gastrocnemius muscle. Numbers of animals are as described in [Fig. 1](#F1){ref-type="fig"}. Data are mean ± SEM. \**P* \< 0.05; \*\**P* \< 0.01. C, controls; r.U., relative units; T, trained mice.](zdb0011164210002){#F2}

![mRNA expression of transcriptional activators and coactivators of mitochondrial biogenesis after chronic exercise. Results are from real-time PCR analyses in skeletal muscle samples. *A*: Nuclear respiratory factor 1 (*NRF-1*). *B*: *NRF-2. C*: Mitofusin-2 (*MFN2*). *D*: Mitochondrial transcription factor A (*Tfam*). All data are normalized per 18S rRNA. Numbers of animals are as described in [Fig. 1](#F1){ref-type="fig"}. Data are means ± SEM. \**P* \< 0.05. C, controls; r.U., relative units; T, trained mice.](zdb0011164210003){#F3}

![Changes in PGC-1α expression and acetylation after chronic exercise. *A*: Real-time PCR analyses of *PGC-1*α mRNA expression in the skeletal muscle of C57BL/6J wild-type mice (black columns) and *ob*/*ob* mice (gray columns). All data are normalized per 18S rRNA. *B*: Densitometry of protein data. Homogenates of skeletal muscle were probed with an antibody detecting PGC-1α (90 kDa). Blots were also probed with GAPDH as a loading control. *C*: Densitometry of immunoprecipitation (IP) experiments performed on skeletal muscle lysates, using PGC-1α for precipitation and an antibody directed against acetyl-lysine or PGC-1α for detection. Data are given as acetylated PGC-1α per total PGC-1α in these samples. All data are means ± SEM. \**P* \< 0.05; \*\**P* \< 0.01. C, controls; r.U., relative units; T, trained mice. *D*: Representative full-size blots of IP experiments.](zdb0011164210004){#F4}

![SIRT1, phospho-AMPK, and phospho-ACC protein expression after chronic exercise. *A*: Densitometry of protein data. Homogenates of skeletal muscle probed with an antibody detecting SIRT1 (110 kDa), phospho-AMPK (62 kDa, Thr172), AMPK (62kDa), phospho-ACC (280 kDa, Ser79), ACC (280 kDa), and GAPDH (42 kDa) as a loading control. Data are means ± SEM. \*\**P* \< 0.01. C, control animals; r.U., relative units; T, trained animals. *B*: Representative Western blots.](zdb0011164210005){#F5}

Besides PGC-1α deacetylation at various lysines by SIRT1, phosphorylation of PGC-1α by AMPK at residues Thr177 and Ser538 was suggested to result in a more active protein ([@B15]). Both mechanisms have been described to occur in response to exercise and contribute to training-induced changes in mitochondrial biogenesis ([@B11],[@B19]). Indeed, chronic exercise resulted in AMPK activation and increased phosphorylation of acetyl-CoA carboxylase in wild-type mice ([Fig. 5](#F5){ref-type="fig"}). Phosphorylation of AMPK or ACC was, however, not altered in *ob/ob* mice after exercise ([Fig. 5](#F5){ref-type="fig"}). Even when muscles were harvested and analyzed shortly after the last training session (30 min, 2 h) to identify short-lived effects, no change in AMPK activation or PGC-1α expression/acetylation was observed in the *ob/ob* mice (not shown). The protein expression of α-AMPK ([Fig. 5](#F5){ref-type="fig"}), α-1 or α-2 AMPK (not shown), was not altered by treadmill exercise in any of the groups. A single session of exhaustive exercise was sufficient to reduce PGC-1α acetylation, increase AMPK phosphorylation, and increase *ND5* and *CYTB* mRNA expression in wild-type mice, if animals were killed 6 h after the end of exercise (supplementary Figure 1, available in an online appendix at <http://diabetes.diabetesjournals.org/cgi/content/full/db10-0331/DC1>). When animals were killed 24 h after exercise, changes induced by this single exercise session were no longer detectable (supplementary Figure 2).

Influence of chronic exercise on skeletal muscle mitochondrial function.
------------------------------------------------------------------------

Pyruvate- and succinate-dependent respiration was lower in untrained *ob/ob* animals than in C57BL/6J mice, but 3 months of chronic exercise resulted in increased succinate-dependent respiration in these mice ([Fig. 6](#F6){ref-type="fig"}*A*). A typical feature of an impaired respiratory chain function is the reduction in the activity of complex I and IV ([@B35]), both containing proteins transcribed from the mitochondrial DNA. Here we show that the skeletal muscle of obese animals demonstrated a significant reduction in complex I activity, and 3 months of exercise training resulted in a higher activity in C57BL/6J and *ob/ob* mice ([Fig. 6](#F6){ref-type="fig"}*B*). The complex I activity in trained *ob/ob* mice, however, was only mildly increased and significantly lower than in untrained wild-type mice (*P* \< 0.05). Complex IV ([Fig. 6](#F6){ref-type="fig"}*B*) and the other complexes (not shown) of the respiratory chain demonstrated only minor changes related to obesity or physical activity. Because PGC-1α was shown to be of particular importance in slow-twitch fibers ([@B8]), microrespirometry and enzymatic measurements were performed on soleus muscle as well, which is also predominantly composed of slow type I fibers and yielded comparable results (not shown).

![Mitochondrial function after chronic exercise. *A*: Active rates of respiration (state 3) were measured in saponin-skinned fibers in the presence of 5 mmol/l ADP and either 10 mmol/l pyruvate (Pyr) + 2 mmol/l malate or 10 mmol/l succinate (Succ) + 5 μmol/l rotenone. Rates of respiration are given as pmol O~2~/second/mg wet weight. *B*: Effects on enzymatic activity of the respiratory chain complexes. Citrate synthase (CS) normalized complex I activity (rotenone-sensitive NADH:CoQ~1~ oxidoreductase) is higher in the skeletal muscle of all trained mice (hatched columns) compared with the respective controls. CS normalized activity of complex IV is similar among the groups (numbers of animals as described in [Fig. 1](#F1){ref-type="fig"}). Data are means ± SEM. \**P* \< 0.05. C, controls; T, trained mice.](zdb0011164210006){#F6}

The mRNA expression of enzymes involved in primary cardiolipin synthesis (*CDS*, *PGPS*, *CLS*) was not different between the groups (supplementary Figure 3). To attain its high levels of linoleic acid, newly synthesized cardiolipin must initially undergo remodeling by monolysocardiolipin acyltransferase and tafazzin. Whereas the former enzyme was not altered, we observed a mild increase in tafazzin mRNA in the skeletal muscle of *ob/ob* mice after 3 months of exercise training (supplementary Figure 3).

Effects of leptin and adiponectin on PGC-1α acetylation in vitro.
-----------------------------------------------------------------

Leptin treatment in C2C12 myoblasts resulted in a dose-dependent increase in AMPK phosphorylation and PGC-1α deacetylation as well as a concomitant induction of adiponectin protein expression (supplementary Figure 4*A*). Similarly, adiponectin treatment of C2C12 cells also resulted in AMPK phosphorylation and PGC-1α deacetylation (supplementary Figure 4*B*). The observed effects of adiponectin were abolished in C2C12 myoblasts overexpressing a mutant PGC-1α lacking the two AMPK phosphorylation sites compared with cells overexpressing wild-type PGC-1α or cells expressing the empty plasmid.

DISCUSSION
==========

The present study demonstrates that enhanced mitochondrial biogenesis ([Fig. 2](#F2){ref-type="fig"}) induced by chronic exercise is paralleled by PGC-1α deacetylation ([Fig. 4](#F4){ref-type="fig"}), SIRT1 protein induction, and increased phosphorylation of AMPK and ACC ([Fig. 5](#F5){ref-type="fig"}) in wild-type mice. Although none of these exercise-induced changes were detected in *ob/ob* mice, comparable effects on mitochondrial respiration ([Fig. 6](#F6){ref-type="fig"}) were observed.

All mice were trained at a speed of 15 m/min, which is a moderate speed compared with some other studies described in the literature. Critical speed was tested in *ob/ob* mice and used accordingly in wild-type mice. Exhaustion in both mouse strains occurred after ∼60--70 min at this speed. As deducted from the time course of blood lactate levels in the two mouse strains, the process of adaptation to chronic exercise differs between the C57BL/6J and the *ob/ob* mice. Future studies are needed to elucidate the mechanisms underlying these differences. Measurements of maximal oxygen uptake or heart rate under exercise conditions may yield more conclusive data ([@B36]) but require additional equipment, which was not available for the present study.

Three months of exercise resulted in enhanced mitochondrial biogenesis and respiration in wild-type mice, together with PGC-1α deacetylation ([Fig. 4](#F4){ref-type="fig"}), AMPK phosphorylation, and SIRT1 protein induction ([Fig. 5](#F5){ref-type="fig"}), which suggests that these may play a role for the mitochondrial biogenic response. No change in any mitochondrial biogenic parameter including citrate synthase occurred in the *ob/ob* mice with training, despite the fact that they ran at a rate close to their maximum. A single session of exercise had comparable effects on PGC-1α, AMPK, SIRT1, and the mRNA expression of primary mitochondrial transcripts (supplementary Fig. 1). This suggests the involvement of fast-acting mechanisms. Long-term maintenance, however, appears to require chronic exercise or repetitive stimuli (supplementary Fig. 2). Although *PGC-1*α mRNA was increased in wild-type mice, we observed only minor changes in PGC-1α protein ([Fig. 4](#F4){ref-type="fig"}). Other studies have shown exercise-induced increases in *PGC-1*α mRNA ([@B37]) and protein ([@B38]) in skeletal muscle. However, while our mice performed moderate chronic exercise for 3 months, these studies ([@B37],[@B38]) used rats that were trained for 5--7 days. Furthermore, a similar study performed in mice (8 weeks voluntary wheel running) demonstrated that no change in PGC-1α protein was evident in plantaris and soleus muscle, although changes in mitochondrial gene expression were observed ([@B39]).

To our knowledge, this is the first study showing that chronic exercise has similar effects on SIRT1 protein expression and PGC-1α acetylation as previously shown by fasting ([@B7],[@B16]) or a single exercise session ([@B19]). SIRT1-mediated lysine deacetylation can be mimicked by resveratrol resulting in increased aerobic capacity and expression of oxphos genes, together with decreased PGC-1α acetylation ([@B17]). Gerhart-Hines et al. ([@B16]) showed that SIRT1 deacetylation of PGC-1α is required for activation of mitochondrial fatty acid oxidation genes as well as oxphos genes. The present study suggests that SIRT1 is involved in exercise-induced changes in mitochondrial gene expression, biogenesis, and respiration in wild-type mice ([Fig. 5](#F5){ref-type="fig"}). The ratio of the mitochondrial redox pair NADH/NAD is ∼80--100 under muscle resting conditions, but during intense exercise, falls to 2--3 ([@B35],[@B40]). Because SIRT1 is activated by NAD ([@B41]), the repeated decrease in the NADH/NAD ratio during chronic exercise may stimulate SIRT1, as observed here in mouse muscular SIRT1 protein expression ([Fig. 5](#F5){ref-type="fig"}) or in the heart of old rats ([@B18]). However, the mechanisms leading to the lack of a SIRT1 response in *ob/ob* mice require further investigation.

Despite a similar degree of chronic exercise, the *ob/ob* mice did not respond to the stimulatory effects of exercise training (12 weeks) in any of the parameters of mitochondrial biogenesis ([Figs. 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}) or indicators of insulin sensitivity ([Table 2](#T2){ref-type="table"}). This suggests that the disturbed leptin signaling contributes to the lack of mitochondrial biogenesis via AMPK/SIRT1/PGC-1α. Similarly, it was shown that leptin is necessary for basal and cold-stimulated PGC-1α expression in brown adipose tissue in *ob/ob* mice ([@B42]). Chronic exercise resulted in a significant increase in AMPK phosphorylation in wild-type mice ([Fig. 5](#F5){ref-type="fig"}). Increased phosphorylation of AMPK was shown to occur after a single session of treadmill running ([@B19],[@B43]) and after chronic exercise in mouse skeletal muscle ([@B44]). However, others have shown no differences between trained or nontrained gastrocnemius muscles in rats ([@B45]). Furthermore, the stimulatory effects of an acute session of exercise on α-2 AMPK activity were lower in trained compared with untrained rats ([@B46]). The reason for these discrepancies in AMPK phosphorylation is not clear at this time but species differences may exist. *Ob/ob* mice have significantly higher serum TNF-α levels than wild-type mice ([Table 2](#T2){ref-type="table"}). This may have contributed to the reduction in AMPK signaling as shown by others ([@B27]). Plasma adiponectin levels in *ob/ob* mice are low ([Table 2](#T2){ref-type="table"}), and leptin treatment increases these plasma levels markedly ([@B26]). The lack of AMPK activation in *ob/ob* mice ([Fig. 5](#F5){ref-type="fig"}) correlated with plasma adiponectin ([Table 2](#T2){ref-type="table"}) in these mice (*R*^2^ = 0.67, *P* \< 0.05). Accordingly, leptin deficiency is associated with impaired mitochondria ([@B25]) and reduced muscle AMPK phosphorylation ([@B27]).

Leptin ([@B22]) and adiponectin ([@B23]) stimulate AMPK and may thus influence mitochondrial biogenesis via increased phosphorylation of PGC-1α ([@B12]). Although chronic leptin treatment in rodents was shown to increase AMPK expression and activation ([@B47]), others did not detect significant changes in the expression of mitochondrial genes in response to leptin treatment compared with pair-fed mice ([@B48]). Furthermore, whereas leptin-mediated activation of AMPK was demonstrated in H9C2 cardiomyoblasts ([@B49]), others have reported that leptin attenuates AMPK activation induced by globular or full-length adiponectin in L6 myotubes ([@B50]). Thus, whereas adiponectin has consistently been shown to activate AMPK, the effects of leptin are more obscure and may depend on additional not-yet-identified coactivators. Our in vitro experiments in C2C12 myoblasts demonstrated an increased AMPK phosphorylation and reduced PGC-1α acetylation after leptin as well as adiponectin treatment (supplementary Fig. 4A). Leptin treatment also resulted in the induction of adiponectin protein expression. Thus, the effects of leptin on AMPK and PGC-1α might be mediated via adiponectin. The observed direct effects of adiponectin were abolished in C2C12 myoblasts overexpressing mutant PGC-1α lacking the two AMPK phosphorylation sites (supplementary Fig. 4B). This suggests that direct phosphorylation of PGC-1α by AMPK is required for adipocytokine-induced PGC-1α deacetylation. The mechanisms underlying the concomitant effect of adiponectin on PGC-1α deacetylation and AMPK activation as well as the increased expression of adiponectin in C2C12 myoblasts after leptin treatment will require further investigations. The interaction between PGC-1α deacetylation by SIRT1 and the AICAR-induced PGC-1α phosphorylation have been investigated recently by others ([@B19]). An adiponectin-mediated mechanism can also be envisioned in wild-type mice, which demonstrate a strong increase in adiponectin plasma levels after chronic exercise ([Table 2](#T2){ref-type="table"}). Leptin and adiponectin plasma levels in *ob/ob* mice on the other hand remain low in sedentary as well as in trained obese mice ([Table 2](#T2){ref-type="table"}). Accordingly, it was demonstrated recently that mice with muscle-specific disruption of AdipoR1 show reduced adiponectin-mediated activation of AMPK and SIRT1 together with reduced PGC-1α expression and mitochondrial content ([@B51]).

The experimental design of our study does not allow a conclusion concerning a superior role of AMPK or SIRT1, since we found similar changes in both, putatively promoting mitochondrial biogenesis. However, others have recently shown that AMPK enhances SIRT1 activity by increasing cellular NAD^+^ levels, resulting in the deacetylation of various SIRT1 targets ([@B19]). The *ob/ob* mice have a major deficit in both pathways, which may have contributed to the complete lack of a mitochondrial biogenic response. Data from DNA microarrays have shown that PGC-1α target genes are coordinately downregulated in diabetic humans ([@B2],[@B52]). Although basal expression of PGC-1α target genes was not impaired, the severely obese *ob/ob* mice did not respond to the stimulatory effects of chronic exercise with increased mRNA expression of *PGC-1*α, *Tfam* ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}), or PGC-1α target genes ([Fig. 2](#F2){ref-type="fig"}).

The obese *ob/ob* mice showed a mild increase in succinate-dependent respiration and complex I activity ([Fig. 6](#F6){ref-type="fig"}), although no signs of mitochondrial biogenesis or changes of the AMPK/SIRT1/PGC-1α signaling pathway were detected. However, the complex I activity was lower in trained *ob/ob* mice than in untrained wild-type mice ([Fig. 6](#F6){ref-type="fig"}). Complex I catalytic activity critically depends on the surrounding phospholipid environment, in particular on cardiolipin ([@B53]), which is the main functional phospholipid of the mitochondrial inner membrane. Cardiolipin content falls in response to decreased muscle performance, and this fall precedes the loss of enzyme activity during decreases in mitochondrial content ([@B54]). A recent study ([@B33]) showed that exercise combined with weight loss resulted in increased oxidative enzyme activity in skeletal muscle without a significant increase in mitochondrial biogenesis, as concluded from mtDNA content. The authors suggest that the increase in mitochondrial cardiolipin facilitates the formation of mitochondrial supercomplexes with enhanced efficiency of electron transport ([@B33]). A similar mechanism can be envisioned in the severely obese *ob/ob* mice, which showed a moderate increase in complex I activity ([Fig. 6](#F6){ref-type="fig"}) but no change in the expression of primary mitochondrial transcripts ([Fig. 2](#F2){ref-type="fig"}) or transcription factors involved in mitochondrial biogenesis ([Fig. 3](#F3){ref-type="fig"}). Changes in cardiolipin content or composition may underlie the reduced complex I activity in the *ob/ob* mice. It has been shown in the heart of *ob/ob* mice that cardiolipin composition is altered and contributes to the mitochondrial dysfunction in diabetic cardiomyopathy ([@B55]). However, mitochondrial cardiolipin content or composition was not measured in the present study, since it required the use of freshly isolated mitochondria. After primary cardiolipin synthesis, the tafazzin-mediated cardiolipin remodeling results in a specific set of acyl chains. The mildly increased mRNA expression of tafazzin in trained *ob/ob* mice (supplementary Fig. 3) suggests an increased cardiolipin remodeling. Future studies are needed to elucidate whether the increased tafazzin expression results in altered cardiolipin composition and increased complex I activity in the *ob/ob* mice after chronic exercise.

In summary, chronic exercise induces mitochondrial biogenesis together with changes in indicators of insulin sensitivity and enhanced mitochondrial respiration in wild-type mice, which requires AMPK activation and may involve SIRT1-dependent PGC-1α deacetylation. *Ob/ob* mice show no signs of increased mitochondrial biogenesis after treadmill exercise but similar changes in mitochondrial function as observed in wild-type mice. Thus, *ob/ob* mice appear to have partially adapted to reduced mitochondrial biogenesis by AMPK/SIRT1/PGC-1α--independent mechanisms without mtDNA replication, putatively involving changes in cardiolipin content or composition.
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